A retrospective multi‐center study of treatment, outcome, and prognostic factors in 34 dogs with disseminated aspergillosis in Australia. (27th January 2022)
- Record Type:
- Journal Article
- Title:
- A retrospective multi‐center study of treatment, outcome, and prognostic factors in 34 dogs with disseminated aspergillosis in Australia. (27th January 2022)
- Main Title:
- A retrospective multi‐center study of treatment, outcome, and prognostic factors in 34 dogs with disseminated aspergillosis in Australia
- Authors:
- Lim, Yi Yu
Mansfield, Caroline
Stevenson, Mark
Thompson, Mary
Davies, David
Whitney, Joanna
James, Fleur
Tebb, Anna
Fry, Darren
Buob, Sibylle
Hambrook, Lydia
Boo, Gladys
Dandrieux, Julien R. S. - Abstract:
- Abstract: Background: Disseminated aspergillosis (DA) in dogs has a guarded prognosis and there is a lack of a gold standard treatment protocol. Objective: To retrospectively assess survival times and factors influencing survival times. Animals: Dogs diagnosed with DA from January 2007 to June 2017. Methods: Disseminated aspergillosis case data were retrieved from 13 Australian veterinary referral centers, with a diagnosis confirmed with culture or PCR. Factors influencing survival time after diagnosis were quantified using a Cox proportional hazards regression model. Results: Thirty‐four dogs met the study inclusion criteria. Twenty‐two dogs were treated with antifungal treatment and 12 dogs received no antifungal treatment. Accounting for censoring of dogs that were either still alive on the date of data collection or were loss to follow‐up, dogs treated with itraconazole alone (n = 8) had a median survival time (MST) of 63 (95% CI: 20−272) days compared to 830 (95% CI: 267‐1259) days for the n = 14 dogs that received multimodal antifungal therapy ( χ 2 test statistic 8.6; df = 1; P < .01). The daily hazard of death (DHOD) for dogs with abnormally high serum creatinine concentration at the time of diagnosis was 7.4 (95% CI: 1.9‐29) times that of dogs with serum creatinine within the reference interval. Conclusion and Clinical Importance: Serum creatinine concentration at the time of diagnosis is a useful prognostic indicator for survival after a diagnosis of DA. The MSTAbstract: Background: Disseminated aspergillosis (DA) in dogs has a guarded prognosis and there is a lack of a gold standard treatment protocol. Objective: To retrospectively assess survival times and factors influencing survival times. Animals: Dogs diagnosed with DA from January 2007 to June 2017. Methods: Disseminated aspergillosis case data were retrieved from 13 Australian veterinary referral centers, with a diagnosis confirmed with culture or PCR. Factors influencing survival time after diagnosis were quantified using a Cox proportional hazards regression model. Results: Thirty‐four dogs met the study inclusion criteria. Twenty‐two dogs were treated with antifungal treatment and 12 dogs received no antifungal treatment. Accounting for censoring of dogs that were either still alive on the date of data collection or were loss to follow‐up, dogs treated with itraconazole alone (n = 8) had a median survival time (MST) of 63 (95% CI: 20−272) days compared to 830 (95% CI: 267‐1259) days for the n = 14 dogs that received multimodal antifungal therapy ( χ 2 test statistic 8.6; df = 1; P < .01). The daily hazard of death (DHOD) for dogs with abnormally high serum creatinine concentration at the time of diagnosis was 7.4 (95% CI: 1.9‐29) times that of dogs with serum creatinine within the reference interval. Conclusion and Clinical Importance: Serum creatinine concentration at the time of diagnosis is a useful prognostic indicator for survival after a diagnosis of DA. The MST for dogs treated with multimodal antifungal therapy is longer than itraconazole alone and warrant further investigation ( P < .01). … (more)
- Is Part Of:
- Journal of veterinary internal medicine. Volume 36:Number 2(2022)
- Journal:
- Journal of veterinary internal medicine
- Issue:
- Volume 36:Number 2(2022)
- Issue Display:
- Volume 36, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 36
- Issue:
- 2
- Issue Sort Value:
- 2022-0036-0002-0000
- Page Start:
- 580
- Page End:
- 590
- Publication Date:
- 2022-01-27
- Subjects:
- canine -- median survival time -- outcome -- prognosis
Veterinary medicine -- Periodicals
636.0896 - Journal URLs:
- http://www.jvetintmed.org ↗
http://www3.interscience.wiley.com/journal/118902531/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jvim.16366 ↗
- Languages:
- English
- ISSNs:
- 0891-6640
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5072.365000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26749.xml